Patents by Inventor Sang-lin Kim

Sang-lin Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11881584
    Abstract: A negative electrode active material including natural graphite, wherein a D90/D10, which is the ratio of D90 to D10, is 2.20 or less, a D50 is 6 ?m to 11 ?m, and a BET specific surface area is 2.2 m2/g or less.
    Type: Grant
    Filed: April 2, 2020
    Date of Patent: January 23, 2024
    Assignee: LG ENERGY SOLUTION, LTD.
    Inventors: Li Lin Piao, Je Young Kim, Sang Wook Woo
  • Patent number: 11866338
    Abstract: An anode active material for secondary batteries which has improved cycle swelling characteristics and rapid charge performance, an anode comprising same, and a method for manufacturing same, in which the anode active material is manufactured by modifying the surface of natural graphite particles. The natural graphite particles have a Dmax/Dmin value of 1.6 to 2.1 in the particle size distribution thereof and have, formed in the surface thereof, pores having a diameter of 0.5 ?m to 2.0 ?m.
    Type: Grant
    Filed: January 17, 2020
    Date of Patent: January 9, 2024
    Assignee: LG ENERGY SOLUTION, LTD.
    Inventors: Hee Won Choi, Je Young Kim, Sang Wook Woo, Li Lin Piao
  • Patent number: 11863826
    Abstract: Systems and methods are provided herein for providing a storyline based media content. At least two storylines may be identified, each storyline specifying an order of providing a plurality of episodes from a plurality of interrelated series. Identifiers of the plurality of episodes are displayed. Then identifiers of a first set of the plurality of episodes that are relevant to the first storyline are graphically modified to indicate relevance to the first storyline. Identifiers of a second set of the plurality of episodes that are relevant to the second storyline are also graphically modified to indicate relevance to the second storyline. A first and second storyline identifier are generating for display to enable storyline selection. The interrelated series are then provided to a user device in the order specified by the selected storyline.
    Type: Grant
    Filed: April 22, 2022
    Date of Patent: January 2, 2024
    Assignee: Rovi Guides, Inc.
    Inventors: Rowena Young, Sang Mo Kim, Edison Lin, Milan Patel
  • Patent number: 11862799
    Abstract: An anode active material for a secondary battery that has improved cycle swelling properties and rapid charge performance, an anode comprising same, and a method for manufacturing same. The anode active material is a mixture of artificial graphite and spherical natural graphite, wherein the spherical natural graphite has an average particle diameter (D 50) of 12 ?m or less, with D 90-D 10 value ranging from 5 ?m to 12 ?m.
    Type: Grant
    Filed: December 10, 2019
    Date of Patent: January 2, 2024
    Assignee: LG ENERGY SOLUTION, LTD.
    Inventors: Hee Won Choi, Je Young Kim, Sang Wook Woo, Li Lin Piao
  • Patent number: 11799072
    Abstract: An anode active material for a secondary battery, which has improved cycle swelling properties and rapid charge performance, an anode comprising an anode active material for a secondary battery, and a method for manufacturing same. The anode active material is a mixture of scaly natural graphite and spherical natural graphite. An average particle diameter (D50) of the scaly natural graphite is 10 ?m to 15 ?m and an average particle diameter (D50) of the spherical natural graphite is 14 ?m or less.
    Type: Grant
    Filed: January 3, 2020
    Date of Patent: October 24, 2023
    Assignee: LG ENERGY SOLUTION, LTD.
    Inventors: Hee Won Choi, Je Young Kim, Sang Wook Woo, Li Lin Piao
  • Publication number: 20210154153
    Abstract: Disclosed is a percutaneous absorption formulation containing melatonin which is a pharmacologically active substance useful for treating insomniac patients and sleep disorder patients.
    Type: Application
    Filed: October 27, 2017
    Publication date: May 27, 2021
    Inventors: Jung Sik LEE, Sun Ho LEE, Mun Seok HAN, Woo Young LEE, Sang Lin KIM, Han Ki KIM
  • Patent number: 8543376
    Abstract: Disclosed are a joint decoding apparatus and a joint decoding method that joins a tokenization process and a translation process. More particularly, the present disclosure can generate all available candidate tokens, reduce translation errors, and obtain an optimal translation result by jointly conducting a decoding by simultaneously conducting the tokenization process and the translation process for an input character sequence while decoding.
    Type: Grant
    Filed: May 25, 2011
    Date of Patent: September 24, 2013
    Assignee: SK Planet Co., Ltd
    Inventors: Young Sook Hwang, Sang-Bum Kim, Chang Hao Yin, Xinyan Xiao, Yang Liu, Qun Liu, Shouxun Lin
  • Patent number: 8003850
    Abstract: Provided is a method for producing a target protein via cultivation of transgenic plant cells comprising a promoter capable of expressing the protein under sugar-free conditions in the response to the depletion of sugar and a gene encoding the target protein, without exchange of a cell growth medium with a sugar-depleted medium comprising the addition of an amino acid mixture to the sugar-rich medium used to grow the plant cells.
    Type: Grant
    Filed: September 19, 2007
    Date of Patent: August 23, 2011
    Assignee: Boryung Pharmaceutical Co., Ltd.
    Inventors: Sang-Lin Kim, Hyun-Kwang Tan, Sang-Min Lim, Wuk-Sang Ryu, Hahn-Sun Jung, Song-Jae Lee, Cheon-Ik Park, Seung-Hoon Kang, Dong-Il Kim
  • Publication number: 20100189717
    Abstract: The present invention provides a recombinant vector pBI-3D-hGalT or pBI-35S-hGalT containing a human ?1,4-galactosyltransferase gene; a cell line transformed with a recombinant vector pMYN414 containing a cytotoxic T-lymphocyte anti-gen A-immunoglobulin (CTLA4Ig) fusion protein gene and the recombinant vector pBI-3D-hGalT or pBI-355-hGalT; and a method for producing a plant-derived recombinant human CTLA4Ig (CTLA4Igp) fusion protein with a human glycan structure using the same. The plant cell-derived recombinant human CTLA4Ig fusion protein (CTLA4Igp), which has a human glycan structure and is produced according to the present invention, exhibits an improved in vivo half life as compared to conventional plant-derived proteins, due to the presence of a human-like glycan structure.
    Type: Application
    Filed: July 9, 2008
    Publication date: July 29, 2010
    Applicant: Boryung Pharmaceutical Co., Ltd.
    Inventors: Sang-Lin Kim, Hyun-Kwang Tan, Sang-Min Lim, Wuk-Sang Ryu, Hahn-Sun Jung, Song-Jae Lee, Cheon-Ik Park, Seung-Hoon Kang, Dong Il Kim
  • Publication number: 20090181428
    Abstract: Provided is a method for producing a target protein via cultivation of transgenic plant cells comprising a promoter capable of expressing the protein under sugar-free conditions or in response to the depletion of sugar and a gene encoding the target protein, without exchange of a cell growth medium with a sugar-depleted medium. The method comprises 1) culturing transgenic plant cells in a sugar-rich medium to grow plant cells; and 2) culturing the transgenic plant cells with addition of an amino acid mixture to the culture of Step 1 without exchange of a cell growth medium with a sugar-depleted medium, thereby expressing a target protein.
    Type: Application
    Filed: September 19, 2007
    Publication date: July 16, 2009
    Applicant: BORYUNG PHARMACEUTICAL CO., LTD.
    Inventors: Sang-Lin Kim, Hyun-Kwang Tan, Sang-Min Lim, Wuk-Sang Ryu, Hahn-Sun Jung, Song-Jae Lee, Cheon-Ik Park, Seung-Hoon Kang, Dong-Il Kim
  • Patent number: 7485656
    Abstract: An antibacterial composition for external application, particularly, a remedial formulation for external use containing fluconazole is disclosed. The formulation comprises a base material, 0.1-5.0 percent by weight of fluconazole and 1.0-40.0 percent by weight of any one compound selected from a group consisting of fatty acid, fatty alcohol, higher fatty acid ester and lower alcohol based on weight of the base material. The composition according to the present invention has various advantages of a favorable absorption into a system through the skin of a human body and delivery of active material into horny layer of the skin, a reduced skin stimulation and an excellent stability. Therefore, the composition is efficiently useable in a medical treatment application for dermatomycosis-related infectious diseases including tinea pedis, tinea corporis, tinea cruris, tinea versicolor and/or candidiasis and the like.
    Type: Grant
    Filed: February 7, 2002
    Date of Patent: February 3, 2009
    Assignee: Boryung Pharmaceutical Co., Ltd.
    Inventors: Sang-Lin Kim, Hyun-Kwang Tan, Jun-Sik Kim, Ho-Beom Lee, Geun-Hong Min, Hae-Won Ryou
  • Patent number: 7309788
    Abstract: A process for preparing pyrimidinone compound and salts thereof The method of the present invention enables the convenience to produce the pyrimidinone derivatives in high yields, which pyrimidinone compounds are useful for treating cardiovascular diseases caused by binding angiotensin II to its receptors, through antagonistic activity against angiotensin II receptors.
    Type: Grant
    Filed: September 21, 2001
    Date of Patent: December 18, 2007
    Assignee: Boryung Pharmaceutical Co., Ltd.
    Inventors: Sang-Lin Kim, Ji-Han Kim, Jung-Bok Lee, Byoung-Wug Yoo, Hyun-Kwang Tan
  • Publication number: 20040266800
    Abstract: A process for preparing pyrimidinone compound and salts thereof The method of the present invention enables the convenience to produce the pyrimidinone derivatives in high yields, which pyrimidinone compounds are useful for treating cardiovascular diseases caused by binding angiotensin II to its receptors, through antagonistic activity against angiotensin II receptors.
    Type: Application
    Filed: August 25, 2004
    Publication date: December 30, 2004
    Inventors: Sang-Lin Kim, Ji-Han Kim, Jung-Bok Lee, Byoung-Wug Yoo, Hyun-Kwang Tan
  • Publication number: 20040122071
    Abstract: An antibacterial composition for external application, particularly, a remedial formulation for external use containing fluconazole is disclosed. The formulation comprises a base material, 0.1-5.0 percent by weight of fluconazole and 1.0-40.0 percent by weight of any one compound selected from a group consisting of fatty acid, fatty alcohol, higher fatty acid ester and lower alcohol based on weight of the base material. The composition according to the present invention has various advantages of a favorable absorption into a system through the skin of a human body and delivery of active material into horny layer of the skin, a reduced skin stimulation and an excellent stability. Therefore, the composition is efficiently useable in a medical treatment application for dermatomycosis-related infectious diseases including tinea pedis, tinea corporis, tinea cruris, tinea versicolor and/or candidiasis and the like.
    Type: Application
    Filed: January 16, 2004
    Publication date: June 24, 2004
    Inventors: Sang-Lin Kim, Hyun-Kwang Tan, Jun-Sik Kim, Ho-Beom Lee, Geun-Hong Min, Hae-Won Ryou
  • Patent number: 6294542
    Abstract: The present invention relates to a novel pyrimidinone compounds and the pharmaceutical acceptable salts thereof having remarkable antagonistic action against angiotensin II receptor, thereby, being useful in treating cardiovascular disease caused by binding angiotensin II to its receptor.
    Type: Grant
    Filed: December 20, 1999
    Date of Patent: September 25, 2001
    Assignee: Boryung Pharmaceutical Co. Ltd.
    Inventors: Jae-hyoung Lee, Kyung-jin Jang, Byoung-wug Yoo, Ji-han Kim, Jae-seog Kang, Sang-lin Kim